Skip to main content

Peer Review reports

From: Effect of thoracic radiotherapy dose on the prognosis of advanced lung adenocarcinoma harboring EGFR mutations

Original Submission
10 Feb 2022 Submitted Original manuscript
14 Feb 2022 Author responded Author comments - Hongyue Qin
Resubmission - Version 2
14 Feb 2022 Submitted Manuscript version 2
24 Feb 2022 Author responded Author comments - Hongyue Qin
Resubmission - Version 3
24 Feb 2022 Submitted Manuscript version 3
7 Mar 2022 Author responded Author comments - Hongyue Qin
Resubmission - Version 4
7 Mar 2022 Submitted Manuscript version 4
22 May 2022 Reviewed Reviewer Report
24 May 2022 Reviewed Reviewer Report
8 Jun 2022 Author responded Author comments - Hongyue Qin
Resubmission - Version 5
8 Jun 2022 Submitted Manuscript version 5
23 Jun 2022 Reviewed Reviewer Report
26 Jun 2022 Reviewed Reviewer Report
13 Jul 2022 Author responded Author comments - Hongyue Qin
Resubmission - Version 6
13 Jul 2022 Submitted Manuscript version 6
16 Aug 2022 Author responded Author comments - Hongyue Qin
Resubmission - Version 7
16 Aug 2022 Submitted Manuscript version 7
Publishing
14 Sep 2022 Editorially accepted
24 Sep 2022 Article published 10.1186/s12885-022-10095-4

You can find further information about peer review here.

Back to article page